Insights

This is an 'occasional series (typically every other month) on key issues identified from either current events or from on going analysis of the database.  We hope that you find it interesting. 

You can register to receive this series automatically by email by completing the box on the left.

How Affordable is a New Cancer Treatment?

In the climate of increasing number of people developing cancer and cancer treatments having premium prices, many companies are releasing break through drugs at high prices. In some markets national health plans may cover the cost of pharmaceuticals but in many global markets the patient needs to either totally or partially self-finance. There is also a growing awareness that health insurances and government programmes cannot always continue to pay for the most expensive cancer therapies due to capping of finances available and hence even in markets with well-established government and insurance paying programmes there may be a need to self-finance.

Click here to read:

Feb 2018